Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (41-50 of 606) with videos related to

Pageof 61
Sort By:
The Journal of Biological Chemistry|July 25, 1989
In vitro requirements for N4 RNA polymerase II-specific initiationK Abravaya, L B Rothman-Denes
Neuropeptides|April 1, 1986
Chronic iminodipropionitrile (IDPN) causes no changes in the rat brain phencyclidine (PCP) receptorR B Rothman, J L Cadet
Diabetes, Obesity & Metabolism|September 8, 2011
Phentermine therapy for obesity does not elevate blood pressureE J Hendricks, R B Rothman
Molecular Neurobiology|August 1, 1995
A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909R B Rothman, J R Glowa
The Journal of Clinical Investigation|February 18, 2004
Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cellsDaphne C Tsitoura, Paul B Rothman
Neurochemical Research|November 1, 1982
Interaction of naloxone with the opioid receptor complex in vitroR B Rothman, T C Westfall
Journal of Bacteriology|November 18, 2008
The tail sheath of bacteriophage N4 interacts with the Escherichia coli receptorJennifer McPartland, Lucia B Rothman-Denes
Advances in Immunology|September 17, 2009
Chapter 3: Role of SOCS in allergic and innate immune responsesSuzanne L Cassel, Paul B Rothman
Annals of the New York Academy of Sciences|November 16, 2006
Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugsRichard B Rothman, Michael H Baumann
American Journal of Therapeutics|December 19, 2008
Appetite suppressants, cardiac valve disease and combination pharmacotherapyRichard B Rothman, Michael H Baumann
Pageof 61

Showing results (41-50 of 606) with videos related to

Sort By:
Pageof 61
The Journal of Biological Chemistry|July 25, 1989
In vitro requirements for N4 RNA polymerase II-specific initiationK Abravaya, L B Rothman-Denes
Neuropeptides|April 1, 1986
Chronic iminodipropionitrile (IDPN) causes no changes in the rat brain phencyclidine (PCP) receptorR B Rothman, J L Cadet
Diabetes, Obesity & Metabolism|September 8, 2011
Phentermine therapy for obesity does not elevate blood pressureE J Hendricks, R B Rothman
Molecular Neurobiology|August 1, 1995
A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909R B Rothman, J R Glowa
The Journal of Clinical Investigation|February 18, 2004
Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cellsDaphne C Tsitoura, Paul B Rothman
Neurochemical Research|November 1, 1982
Interaction of naloxone with the opioid receptor complex in vitroR B Rothman, T C Westfall
Journal of Bacteriology|November 18, 2008
The tail sheath of bacteriophage N4 interacts with the Escherichia coli receptorJennifer McPartland, Lucia B Rothman-Denes
Advances in Immunology|September 17, 2009
Chapter 3: Role of SOCS in allergic and innate immune responsesSuzanne L Cassel, Paul B Rothman
Annals of the New York Academy of Sciences|November 16, 2006
Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugsRichard B Rothman, Michael H Baumann
American Journal of Therapeutics|December 19, 2008
Appetite suppressants, cardiac valve disease and combination pharmacotherapyRichard B Rothman, Michael H Baumann
Pageof 61